8-K 1 c67056e8-k.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2001 MOLECULAR DIAGNOSTICS, INC. (Exact Name of Company as Specified in Its Charter) DELAWARE 0-935 36-4296006 (State or other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification Number) 414 NORTH ORLEANS STREET SUITE 510 CHICAGO, ILLINOIS 60610 (Address and Zip Code of Principal Executive Offices) (312) 222-9550 (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS. On December 31, 2001, Leonard R. Prange tendered his resignation from his positions as President, Chief Operating Officer, Chief Financial Officer and Secretary of Molecular Diagnostics, Inc. (the "Company"). The Company's Board of Directors has appointed Peter P. Gombrich, the Chairman of the Board of Directors and Chief Executive Officer, to fill the vacancies until a successor is hired. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLECULAR DIAGNOSTICS, INC. /s/ Peter P. Gombrich ----------------------------- Peter P. Gombrich President Date: January 18, 2002